New study finds hospitals prescribe more medicines, and more expensive medicines, after joining 340B program
By Nicole Longo | December 18, 2018
Data and analyses continue to show the 340B program influences prescribing trends at 340B hospitals – ultimately costing patients and our health care system more money. The Government...
Read More
New study finds some hospitals mark up medicine prices at least 700 percent
By Holly Campbell | September 5, 2018
A new analysis from The Moran Company found nearly one in five hospitals marks up medicine prices 700 percent or more. With this 700 percent markup, a $150 medicine purchased by a hospital could...
Read More
New analysis finds 340B medicine sales hit record high in 2017 and continue to grow as a share of total drug spending
By Nicole Longo | August 20, 2018
How big is the 340B program, and what share of the prescription medicine market does it represent? Those are popular questions of late as stakeholders discuss ways to improve the 340B program. In...
Read More
PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs
By Holly Campbell | July 16, 2018
Today, PhRMA submitted comprehensive comments to the Department of Health and Human Services (HHS) request for information (RFI), HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs....
Read More
GAO again recommends improvements to 340B program
By Nicole Longo | July 11, 2018
Over the years, the non-partisan Government Accountability Office (GAO) has reviewed various aspects of the 340B program, finding areas for improvement and providing recommendations. The latest...
Read More
ICYMI - Analysis finds higher outpatient drug spending at 340B hospitals
By Nicole Longo | June 18, 2018
Did you know 340B hospitals prescribe more medicines or more expensive medicines? A recent analysis by Milliman, commissioned by PhRMA, found hospitals participating in the 340B drug pricing...
Read More
340B Spotlight: How much money are hospitals pocketing under 340B and what are they doing with those profits?
By Nicole Longo | March 28, 2018
The once little-known 340B drug discount program, which was designed to help low-income, uninsured or otherwise vulnerable patients access prescription medicines at safety-net facilities, is now a...
Read More
340B Spotlight: Hospital system adds voice to comments about flawed 340B program
By Nicole Longo | February 2, 2018
Each week, more and more groups are calling attention to the 340B program and its myriad problems. Here’s a quick recap of some of the latest voices out there.
Read More
Fact Check Friday: The truth about the cost of 340B to patients
By Nicole Longo | January 26, 2018
The 340B program was designed to increase access to medicines for vulnerable or uninsured patients through safety-net facilities, but all signs point to 340B doing the opposite – distorting the...
Read More
Medicare Monday (100)
340B Spotlight (37)
Cost & Consequence (0)
